GUELPH, ON, July 13 /PRNewswire-FirstCall/ - BIOREM Inc.
("Biorem" or "the Company") (TSX-V: BRM), a leading clean
technology company that designs and supplies high-efficiency
biological-based air emissions control systems, announced today the
receipt of three orders for its systems, totalling $1.3 million.
The first order is for the Company's two-stage skid-mounted SK
series product, which will be used to treat hydrogen sulphide
emissions from a wastewater treatment plant located in the South
East region of the United States.
The second order is for a modular Biocube system to treat hydrogen
sulphide and odorous air collected from the wet well of a pumping
station in the western coastal region of the United States. The third order was
received from the greater Toronto
area and is for a large biofilter system utilizing Biorem's
Biosorbens(R) media to treat odors from a collections system.
"We continue to maintain a solid pace in winning orders for our
air emissions control systems, typically beating out our
competition on both the superior economics and performance of our
industry leading systems," said Peter
Bruijns, President and CEO.
About BIOREM Inc.
Biorem is a leading clean technology company that designs,
manufactures and distributes a comprehensive line of
high-efficiency biological-based air emissions control systems.
These systems are used to eliminate odors, volatile organic
compounds (VOCs) and hazardous air pollutants (HAPs), and for the
conditioning of biogas renewable energy. With sales and
manufacturing offices across the continent, a dedicated research
facility, a worldwide sales representative network and more than
600 installed systems worldwide, Biorem not only offers
state-of-the-art technology-based products but also peace of mind
for municipalities, industrial companies and their surrounding
communities. Additional information on Biorem is available on our
website at www.biorem.biz.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This press release contains forward-looking statements based on
current expectations. These forward-looking statements contain
various risks and uncertainties that could cause actual results to
differ materially from those reflected in the forward-looking
statements. Risks and uncertainties about the Company's business
are more fully discussed in the disclosure materials, financial
statements and MD&A filed with the securities regulatory
authorities in Canada on
www.sedar.com
Non-GAAP Measures
"Order Bookings" and "Order Backlog" do not have any
standardized meaning prescribed by Canadian generally accepted
accounting principles ("GAAP") and may not be comparable to
measures presented by other companies.
Order Bookings and Order Backlog are non-GAAP measures that the
Company uses to evaluate its sales performance. Order Bookings are
those binding contracts that the Company enters into with a third
party for the delivery of our products or services. As Order
Bookings are received, the contract value (before any associated
sales taxes) is included in the Order Backlog. The Order Backlog is
reduced by the revenue that is recognized on each project.
SOURCE Biorem Inc.